Pharmacotherapy and other treatments for cocaine abuse and dependence

Current Opinion in Psychiatry
Frank Vocci, Ahmed M Elkashef

Abstract

This review examines progress being made in the treatment of cocaine abuse and dependence, with a particular focus on pharmacotherapies. Medications with apparently very different mechanisms of action have been reported to reduce cocaine use in controlled clinical trials in outpatient settings. This review will summarize the latest findings in this area. Of all the medications tested to date, disulfiram has demonstrated the most consistent effect to reduce cocaine use. Several medications have been reported to reduce cocaine use in double-blind, placebo-controlled clinical trials, namely baclofen, modafinil, tiagabine, and topiramate. All pharmacotherapy trials in cocaine-dependent patients include a behavioral therapy that is common to all participants. Consequently, these pharmacotherapy trials can be considered to evaluate whether the medication is adding to the effect of the behavioral therapy. Confirmatory clinical studies are necessary to replicate the initial efficacy findings for baclofen, modafinil, tiagabine, and topiramate. More research is needed in both cocaine and cocaine-alcohol dependent populations. Once confirmatory studies have been carried out, testing of rational medication combinations with different behav...Continue Reading

References

Feb 1, 1986·Archives of General Psychiatry·F H Gawin, H D Kleber
Apr 1, 1993·The American Journal of Psychiatry·S T HigginsF Foerg
Jan 1, 1996·Psychopharmacology·S T HigginsW K Bickel
Nov 1, 1996·The American Journal of Drug and Alcohol Abuse·E J Wiseman, D E McMillan
Apr 21, 1998·Biological Psychiatry·E F McCance-KatzP Jatlow
Aug 12, 1998·Addictive Behaviors·K M KampmanL E Epperson
Oct 27, 1998·Drug and Alcohol Dependence·E F McCance-KatzP Jatlow
Feb 19, 1999·Journal of Substance Abuse Treatment·D W OslinC P O'Brien
Jul 27, 2000·Annals of the New York Academy of Sciences·D C Roberts, K Brebner
Apr 24, 2001·Addictive Behaviors·J M SchmitzJ Grabowski
May 5, 2001·Expert Opinion on Pharmacotherapy·S C Schachter
Jun 5, 2002·Archives of General Psychiatry·D Dwayne SimpsonKirk M Broome
Sep 10, 2002·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Karen BrebnerDavid C S Roberts
Nov 6, 2002·Psychopharmacology·Danielle C TurnerBarbara J Sahakian
Apr 12, 2003·Drug and Alcohol Dependence·Charles A DackisCharles P O'Brien
Jun 19, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David W OslinCharles P O'Brien
Sep 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rossella VenturaStefano Puglisi-Allegra
May 4, 2004·Biological Psychiatry·Danielle C TurnerBarbara J Sahakian
Jul 9, 2004·Addictive Behaviors·Charla NichKathleen M Carroll
Jul 31, 2004·Drug and Alcohol Dependence·Kyle M KampmanCharles P O'Brien
Sep 17, 2004·The American Journal on Addictions·Joy M SchmitzJohn Grabowski
Nov 5, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Charles A DackisCharles P O'Brien

❮ Previous
Next ❯

Citations

Dec 17, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Frederick Gerard MoellerLiangsuo Ma
Jan 13, 2009·Addiction Biology·George F Koob
Mar 26, 2010·Indian Journal of Pharmacology·Nagesh DasarwarNilesh Kumbhare
Feb 4, 2012·Future Medicinal Chemistry·Craig R Rush, William W Stoops
Sep 1, 2015·Neuropharmacology·Laurie P Sutton, Marc G Caron
Mar 6, 2012·Neuroscience Letters·Pamela SabioniJosé C F Galduróz
Mar 1, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Alberto Salazar-JuárezBenito Antón
Mar 8, 2016·European Journal of Pharmacology·Christelle Froger-Colléaux, Vincent Castagné
Apr 26, 2008·Drug and Alcohol Dependence·S D ComerS L Walsh
Dec 25, 2007·La Presse médicale·Laurent KarilaMichel Reynaud
Oct 31, 2006·Neuropharmacology·T M KorotkovaO A Sergeeva
May 19, 2007·Addiction Biology·Antonio Preti
May 17, 2011·Alcoholism, Clinical and Experimental Research·Henning KrampeHannelore Ehrenreich
Mar 6, 2010·Annals of the New York Academy of Sciences·Alan C Swann
Jan 21, 2014·Neuropharmacology·Christopher S TallaridaScott M Rawls
Sep 14, 2015·The International Journal of Neuropsychopharmacology·Richard De La GarzaDaisy G Y Thompson-Lake
Feb 17, 2015·Drug and Alcohol Dependence·Christopher S TallaridaScott M Rawls
Jan 21, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Richard De La GarzaKathryn A Cunningham
Oct 12, 2007·The International Journal of Neuropsychopharmacology·Laurent KarilaJean Pierre Lépine
May 13, 2008·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Alessandra Diehl ReisRonaldo Laranjeira
Nov 29, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Takato HiranitaJonathan L Katz
Apr 20, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David A ThornJun-Xu Li
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Pier Paolo PaniMarina Davoli
Sep 5, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jae-Chul JungSeikwan Oh
Dec 17, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jae-Chul JungSeikwan Oh
Jun 4, 2010·Journal of Clinical Psychopharmacology·Craig R RushLon R Hays
Jan 16, 2008·Behavioural Pharmacology·Bernard Le FollSteven R Goldberg
Jun 2, 2009·Nature Reviews. Drug Discovery·George F KoobBarbara J Mason
Dec 6, 2012·The Journal of Pharmacology and Experimental Therapeutics·Paul W Czoty, Michael A Nader
Aug 3, 2013·The Journal of Pharmacology and Experimental Therapeutics·Takato HiranitaJonathan L Katz
Nov 5, 2020·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Carolina de Meneses-GayaAcioly L Lacerda

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Fortschritte der Neurologie-Psychiatrie
R ThomasiusArbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Charles DackisCharles P O'Brien
Journal of Clinical Psychopharmacology
Jesse J SuhCharles P O'Brien
© 2022 Meta ULC. All rights reserved